Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v8-EN
Language English English
Date Updated 2020-12-11 2020-12-10
Drug Identification Number 02247766 02247766
Brand name CETROTIDE CETROTIDE
Common or Proper name cetrorelix acetate cetrorelix acetate
Company Name EMD SERONO, A DIVISION OF EMD INC., CANADA EMD SERONO, A DIVISION OF EMD INC., CANADA
Ingredients CETRORELIX CETRORELIX
Strength(s) 0.25MG 0.25MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1 vial 1 vial
ATC code H01CC H01CC
ATC description HYPOTHALAMIC HORMONES HYPOTHALAMIC HORMONES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2020-11-24 2020-11-24
Estimated end date 2020-12-14
Actual end date 2020-12-10 2020-12-10
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Resolved. Resolved.
Health Canada comments